ArticleInternational journal of breast cancer2026

Real-World Safety and Efficacy of Biosimilar Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer: A Prospective Single-Institution Study From India.

Divya Gandrala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.